4,7,10,13-eicosatetraynoic acid has been researched along with dinoprostone in 1 studies
| Studies (4,7,10,13-eicosatetraynoic acid) | Trials (4,7,10,13-eicosatetraynoic acid) | Recent Studies (post-2010) (4,7,10,13-eicosatetraynoic acid) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | 4,7,10,13-eicosatetraynoic acid (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knepel, W; Vlaskovska, M | 1 |
1 other study(ies) available for 4,7,10,13-eicosatetraynoic acid and dinoprostone
| Article | Year |
|---|---|
Beta-endorphin and adrenocorticotropin release from rat adenohypophysis in vitro: evidence for local modulation by arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathway.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Adrenocorticotropic Hormone; Animals; Arachidonic Acids; beta-Endorphin; Catechols; Dinoprostone; Endorphins; In Vitro Techniques; Indomethacin; Male; Masoprocol; Pituitary Gland, Anterior; Prostaglandins E; Pyrazoles; Rats; Rats, Inbred Strains | 1984 |